KDM6B drives epigenetic reprogramming associated with lymphoid stromal cell early commitment and immune properties

• Published in: Science advances Vol. 9; no. 48; p. eadh2708
• Main Authors: Sylvestre, Marvin, Barbier, Nicolas, Sibut, Vonick, Nayar, Saba, Monvoisin, Céline, Leonard, Simon, Saint-Vanne, Julien, Martin, Ansie, Guirriec, Marion, Latour, Maëlle, Jouan, Florence, Baulande, Sylvain, Bohec, Mylène, Verdière, Léa, Mechta-Grigoriou, Fatima, Mourcin, Frédéric, Bertheuil, Nicolas, Barone, Francesca, Tarte, Karin, Roulois, David
• Format: Journal Article
• Language: English
• Published: United States American Association for the Advancement of Science (AAAS) 01-12-2023; American Association for the Advancement of Science
• Series: Science Advances
• Subjects: Animals; Biomedicine and Life Sciences; Cancer; Cell Differentiation - genetics; Epigenesis, Genetic; Health and Medicine; Humans; Immunology; Inflammation; Jumonji Domain-Containing Histone Demethylases - genetics; Life Sciences; Mice; SciAdv r-articles; Stromal Cells; Up-Regulation
• ISSN: 2375-2548; 2375-2548
• DOI: 10.1126/SCIADV.ADH2708

Mature lymphoid stromal cells (LSCs) are key organizers of immune responses within secondary lymphoid organs. Similarly, inflammation-driven tertiary lymphoid structures depend on immunofibroblasts producing lymphoid cytokines and chemokines. Recent studies have explored the origin and heterogeneity of LSC/immunofibroblasts, yet the molecular and epigenetic mechanisms involved in their commitment are still unknown. This study explored the transcriptomic and epigenetic reprogramming underlying LSC/immunofibroblast commitment. We identified the induction of lysine demethylase 6B (KDM6B) as the primary epigenetic driver of early immunofibroblast differentiation. In addition, we observed an enrichment for KDM6B gene signature in murine inflammatory fibroblasts and pathogenic stroma of patients with autoimmune diseases. Last, KDM6B was required for the acquisition of LSC/immunofibroblast functional properties, including the up-regulation of CCL2 and the resulting recruitment of monocytes. Overall, our results reveal epigenetic mechanisms that participate in the early commitment and immune properties of immunofibroblasts and support the use of epigenetic modifiers as fibroblast-targeting strategies in chronic inflammation.